PDF
Corrigendum | Open Access
Lingyun Zhang, Yu Lan, Qi Wang, Yuexia Zhang, Xiaobei Si, "Corrigendum to “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori”", Gastroenterology Research and Practice, vol. 2021, Article ID 9823426, 1 page, 2021. https://doi.org/10.1155/2021/9823426
Corrigendum to “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori”
Lingyun Zhang
,1 Yu Lan,1 Qi Wang,1 Yuexia Zhang,1 and Xiaobei Si11Department of Gastroenterology, Beijing Jishuitan Hospital, NO 68, Hui Nan Road, Changping District, Beijing 100096, China
In the article titled “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori” [1], there was an error in Subjects and Methods. This error is shown below:
“(Wyeth-Palace Pharmaceutical Co., Ltd, 1.0g, BID)” should read “(Wyeth-Palace Pharmaceutical Co., Ltd, 0.1 g, BID).”
References
- L. Zhang, L. Yu, Q. Wang, Y. Zhang, and X. Si, “Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori,” Gastroenterology Research and Practice, vol. 2019, Article ID 9251879, 6 pages, 2019. View at: Publisher Site | Google Scholar
Copyright
Copyright © 2021 Lingyun Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
